{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-061255","form_type":"8-K","ticker":null,"cik":"0001735948","company_name":"Greenbrook TMS Inc.","filed_at":"2024-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.813223+00:00","generated_at":"2026-06-01T23:23:01.089895+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Greenbrook TMS Q1 revenue down 7% to $18.0M; net loss widens 36% to $14.5M","bullets":["Revenue $18.0M (-7% YoY); regional operating loss $2.5M (+401%).","Net loss $14.5M (+36% YoY); diluted EPS -$0.32 vs -$0.34.","130 active treatment centers (down from 162 YoY) due to restructuring plan.","Spravato rollout at 84 centers; medication management at 9; talk therapy in FL and MO.","Change Healthcare ransomware impacted billing/collections in Q1."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-061255","json":"https://secwatch.observer/filing/0001104659-24-061255.json","markdown":"https://secwatch.observer/filing/0001104659-24-061255.md","text":"https://secwatch.observer/filing/0001104659-24-061255.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1735948/000110465924061255/0001104659-24-061255-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1735948/000110465924061255/tm2414236d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T23:23:01.089895+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5ed858802e12dc0b83ee5339c6da064ac7c8eb9b","claim":"Greenbrook TMS Inc. reported first quarter 2024 results: revenue $18.0 million, net income $14.5 million, EPS $(0.32) per share.","evidence_excerpt":"the ransomware cyberattack on Change Healthcare Solutions LLC (“ Change Healthcare ”) that affected the broader healthcare industry, quarterly revenue decreased by only 7% to $18.0 million, down $1.3 million as compared to the first quarter of 2023 (“ Q1 2023 ”). · Regional operating loss increased by 401% in Q1 2024 to $2.5 million, up $2.0 million as compared to","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1735948/000110465924061255/0001104659-24-061255-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter 2024"},{"label":"Revenue","value":"$18.0 million"},{"label":"Net income","value":"$14.5 million"},{"label":"EPS","value":"$(0.32) per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}